메뉴 건너뛰기




Volumn 119, Issue 12, 2012, Pages 2703-2705

EPCR encryption induces cellular APC resistance

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR; ENDOTHELIAL PROTEIN C RECEPTOR;

EID: 84858813963     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-400762     Document Type: Note
Times cited : (5)

References (10)
  • 1
    • 84858852559 scopus 로고    scopus 로고
    • sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove
    • Lopez-Sagaseta J, Puy C, Tamayo I, et al. sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove. Blood. 2012;119(12):2914-2921.
    • (2012) Blood , vol.119 , Issue.12 , pp. 2914-2921
    • Lopez-Sagaseta, J.1    Puy, C.2    Tamayo, I.3
  • 2
    • 0027943163 scopus 로고
    • Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor
    • Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 1994;269(42):26486- 26491.
    • (1994) J Biol Chem , vol.269 , Issue.42 , pp. 26486-26491
    • Fukudome, K.1    Esmon, C.T.2
  • 3
    • 34147119744 scopus 로고    scopus 로고
    • The cytoprotective protein C pathway
    • DOI 10.1182/blood-2006-09-003004
    • Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109(8):3161-3172. (Pubitemid 46572500)
    • (2007) Blood , vol.109 , Issue.8 , pp. 3161-3172
    • Mosnier, L.O.1    Zlokovic, B.V.2    Griffin, J.H.3
  • 4
    • 77949304898 scopus 로고    scopus 로고
    • APC resistance: Biological basis and acquired influences
    • Castoldi E, Rosing J. APC resistance: biological basis and acquired influences. J Thromb Haemost. 2010;8(3): 445-453.
    • (2010) J Thromb Haemost , vol.8 , Issue.3 , pp. 445-453
    • Castoldi, E.1    Rosing, J.2
  • 6
    • 36448952375 scopus 로고    scopus 로고
    • CD1 antigen presentation: How it works
    • DOI 10.1038/nri2191, PII NRI2191
    • Barral DC, Brenner MB. CD1 antigen presentation: how it works. Nat Rev Immunol. 2007;7(12):929-941. (Pubitemid 350166056)
    • (2007) Nature Reviews Immunology , vol.7 , Issue.12 , pp. 929-941
    • Barral, D.C.1    Brenner, M.B.2
  • 7
    • 77649231838 scopus 로고    scopus 로고
    • Lipid and glycolipid antigens of CD1d-restricted natural killerTcells
    • VenkataswamyMM,Porcelli SA. Lipid and glycolipid antigens of CD1d-restricted natural killerTcells. Semin Immunol. 2010;22(2):68-78.
    • (2010) Semin Immunol , vol.22 , Issue.2 , pp. 68-78
    • Venkataswamy, M.M.1    Porcelli, S.A.2
  • 8
    • 78650161683 scopus 로고    scopus 로고
    • Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: Roles as biological effectors and biomarkers
    • Mallat Z, Lambeau G, Tedgui A. Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers. Circulation. 2010;122(21):2183-2200.
    • (2010) Circulation , vol.122 , Issue.21 , pp. 2183-2200
    • Mallat, Z.1    Lambeau, G.2    Tedgui, A.3
  • 9
    • 33746728293 scopus 로고    scopus 로고
    • The endothelial protein C receptor
    • DOI 10.1097/01.moh.0000239712.93662.35, PII 0006275220060900000014
    • Esmon CT. The endothelial protein C receptor. Curr Opin Hematol. 2006;13(5):382-385. (Pubitemid 44168461)
    • (2006) Current Opinion in Hematology , vol.13 , Issue.5 , pp. 382-385
    • Esmon, C.T.1
  • 10
    • 77957692112 scopus 로고    scopus 로고
    • Phospholipase A2s: Developing drug targets for atherosclerosis
    • Suckling K. Phospholipase A2s: developing drug targets for atherosclerosis. Atherosclerosis. 2010;212(2):357-366.
    • (2010) Atherosclerosis , vol.212 , Issue.2 , pp. 357-366
    • Suckling, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.